2 completed, 1 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Malignant Brain Tumor: new trials by email Literature Review of Malignant Brain Tumor trials Research Report on Malignant Brain Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children Cabozantinib - Glioblastoma Multiforme, Anaplastic Astrocytoma | Phase 2 | Terminated | Indiana University | 4 | 2017-05-18 | 2022-10-06 |
| Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects DNX-2401, pembrolizumab - Brain Cancer, Brain Neoplasm | Phase 2 | Completed | DNAtrix, Inc. | 49 | 2016-10-06 | 2021-07-15 |
| Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors Indoximod, Temozolomide, Bevacizumab - Glioblastoma Multiforme, Glioma | Phase 1 / Phase 2 | Completed | NewLink Genetics Corporation | 160 | 2014-03-01 | 2024-03-27 |
Brain Neoplasms (3) · Glioblastoma (3) · Glioma (3) · Gliosarcoma (2) · Astrocytoma (1) · Disease (1) · Neoplasms (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Nervous System Diseases (1) · Neuroectodermal Tumors (1)
Brain Diseases (3) · Central Nervous System Diseases (3) · Central Nervous System Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Glandular and Epithelial (3) · Nervous System Neoplasms (3) · Astrocytoma (2) · Neoplasms (2) · Neoplasms, Nerve Tissue (2) · Neoplasms, Neuroepithelial (2) · Nervous System Diseases (2) · Neuroectodermal Tumors (2) · Pathologic Processes (1)
1-methyltryptophan (1) · Antibodies, Monoclonal (1) · Bevacizumab (1) · Oncolytic Virotherapy (1) · Radiosurgery (1) · Spermine Synthase (1) · Temozolomide (1) · cabozantinib (1) · pembrolizumab (1)
DNAtrix, Inc. (1) · Indiana University (1) · NewLink Genetics Corporation (1)
United States (3) · Canada (1)
Nancy Gady, BS (1) · Scott Coven, DO (1)